This study is a single-center, historical prospective cohort study including patients diagnosed with metabolic cardiovascular disease, including hypertension, diabetes, obesity, dyslipidemia, hyperuricemia. The primary outcome of the study is all-cause death and cardiovascular death, and the secondary outcome is major adverse cardiovascular events. We aim to measure associations of established or suspected cardiometabolic disease (CMD) risk factors and cardiovascular disease outcomes in a real-world representative cohort.
Study Type
OBSERVATIONAL
Enrollment
40,000
The First Affiliated Hospital of Sun Yat-sen Univerity
Guangzhou, Guangdong, China
RECRUITINGall-cause mortality
Death due to any cause after enrollment
Time frame: Through study completion, an average of 5 years
Cardiovascular death
Death caused by cardiac causes
Time frame: Through study completion, an average of 5 years
Major adverse cardiovascular events
Including heart failure hospitalization, coronary heart disease, stroke, arrhythmia, valvular heart disease, etc.
Time frame: Through study completion, an average of 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.